http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2227410-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
filingDate 1996-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81e865f2792960e0a28b3ca39f13c4de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eb2c515f6198699c6e07cdbef6ad1d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed2e7e9a837ef9a64697ab3ba0590d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_912d2bbcad60cef3fd968f0d2888e534
publicationDate 1997-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2227410-A1
titleOfInvention Treatment of attention-deficit/hyperactivity disorder
abstract A group of propanamines, norepinephrine uptake inhibitors, are used to treat attention-deficit/hyperactivity disorder.
priorityDate 1995-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453774835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15074120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450102203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426705952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454668499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161610462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10945497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121950

Total number of triples: 54.